Quantcast

Study findings on mineral excipient for enhanced ODTs

In a recent study, scientists confirmed the ability of Omyapharm to formulate orally disintegrating tablets (ODTs) with enhanced mouthfeel and examined their acceptability among healthy volunteers, Omya International said in a press release on Thursday.

According to the company, the multifunctional excipient from Omya is a highly structured mineral based on calcium carbonate and calcium phosphate. The study found that the tablets were well accepted by the volunteers and – in correlation with the in vitro model – disintegrated fast in vivo. Additionally, the compactibility and the physical stability of the tablets were preserved, delivering the high porosity required to absorb the liquid necessary for disintegration. These findings lead to the conclusion that Omyapharm is a highly suitable excipient for ODT dosage forms with a pleasant mouthfeel, the company said.

Furthermore, ODTs are a comfortable and safe drug delivery method beneficial for all patient age groups. The main challenge in ODT development is simultaneously to ensure fast disintegration time, physical stability, taste masking, acceptable mouthfeel as well as a cost-effective production process. This study proves that Omyapharm® as an excipient can be successfully formulated into ODTs without any unpleasant sensation in the mouth. It combines good compactibility with a fast disintegration time, thanks to the high porosity and specific surface properties of the highly structured mineral. This results in harder tablets at low compression forces, the company said.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.